Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
Year: 2008
Type: review
Source: The Lancet Oncology
Authors: Pascal Sève, Charles Dumontet
Institutions: Lyon 1 Université, Inserm, Hospices Civils de Lyon
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2098514397
